-
My Account
In App
My Account
BSE Live
Nov 14, 16:01Prev. Close
417.05
Open Price
415.95
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Nov 14, 15:57Prev. Close
417.00
Open Price
414.75
Bid Price (Qty.)
411.15 (7561)
Offer Price (Qty.)
0.00 (0)
| Cash Flow of Biocon (in Rs. Cr.) | Mar 15 | Mar 14 | Mar 13 | Mar 12 | Mar 11 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | 624.10 | 537.70 | 610.20 | 392.50 | 398.50 | |
| Net CashFlow From Operating Activities | 210.70 | 560.70 | 471.20 | 564.10 | 798.50 | |
| Net Cash Used In Investing Activities | -508.70 | -938.10 | -375.80 | -359.50 | -314.50 | |
| Net Cash Used From Financing Activities | 186.20 | 426.00 | -8.60 | -186.30 | -274.60 | |
| Foreign Exchange Gains / Losses | 6.50 | 34.40 | 18.20 | 29.80 | 9.70 | |
| Adjustments On Amalgamation Merger Demerger Others | 10.90 | 0.00 | 0.00 | -38.10 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | -94.40 | 83.00 | 105.00 | 10.00 | 219.10 | |
| Cash And Cash Equivalents Begin of Year | 557.00 | 474.00 | 369.00 | 359.00 | 139.90 | |
| Cash And Cash Equivalents End Of Year | 462.60 | 557.00 | 474.00 | 369.00 | 359.00 |
14.11.2025
12.11.2025
Biocon Standalone September 2025 Net Sales at Rs 583.30 crore, up 11.02% Y-o-Y
10.11.2025
07.11.2025
